It is already known that heart problems and diseases are caused by excess bad fat.High levels of triglycerides, a type of fat ...

Investing.com -- The Medicines and Healthcare products Regulatory Agency approved a maximum dose of up to 7.2 milligrams per week of Novo Nordisk’s (CSE:NOVOb) weight-loss drug Wegovy for patients ...

From bootstrapping creative side projects to scaling a unified commerce platform, Sreeraman MG shares with TRB the turning ...

The shortage of primary care doctors is a national problem. To cope, a large health system in Massachusetts is using an AI ...

The infotainment system in the U9 Explore Pro is, for the most part, a competent installation. The dual screens are bright and the system latches on to its wireless Apple CarPlay or Android Auto ...

Eligible patients can now get the Wegovy pill — the first oral GLP-1 treatment for weight management in adults — at Hy-Vee ...

Reshaping graphene from flat sheets into compact particles solves a key manufacturing problem, enabling printable conductive ...

Using standard THC units, researchers identified weekly consumption thresholds beyond which the risk for cannabis use ...

UK MHRA approves up to 7.2mg dose of semaglutide for patients with obesity only: United Kingdom Saturday, January 17, 2026, 13:00 Hrs [IST] The UK Medicines and Healthcare product ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...